Harokopio University
Επίδραση της χορήγησης ελαιολάδου πλούσιου σε φαινολικές ενώσεις στη λειτουργικότητα αιμοπεταλίων και σε βιοχημικούς δείκτες υγείας διαβητικών ασθενών
Abstract
dc:descriptionIntroduction: The consumption of foods containing ingredients with mild antiplatelet action could contribute to the daily suppression of platelet hyperactivation in patients with Type 2 Diabetes Mellitus (T2DM). Extra virgin olive oil could serve as such a food, primarily due to the phenolic compounds it contains, particularly oleocanthal, whose mechanism of action justifies a strong antiplatelet and anti-inflammatory effect. The main objectives of this study were: a) to compare the in vitro antiplatelet action of the most important phenolic compounds in olive oil on platelets from healthy volunteers, b) to investigate whether phenolic extracts from oils rich in oleocanthal can exhibit in vitro antiplatelet action, and c) to explore whether the direct administration of oleocanthal-rich EVOO, integrated into a carbohydrate meal, contributes dose-dependently to the improvement of the kinetics of metabolic markers and platelet activation in patients with T2DM. Methodology: In vitro experiments were conducted on isolated platelet-rich plasma from 16 healthy volunteers. Antiplatelet activity was evaluated using light transmission aggregometry, employing ADP and TRAP as activating agents. A postprandial study was conducted in which ten patients with T2DM consumed five isocaloric meals that contained 120 g of white bread combined with: (i) 39 g of butter (BU), (ii) 39 g of butter plus 400 mg of ibuprofen (BU-IBU), (iii) 40 mL of olive oil with phenolic content < 10 mg/Kg (OO), (iv) 40 mL of olive oil with 250 mg/Kg oleocanthal (OO250), and (v) 40 mL of olive oil with 500 mg/Kg oleocanthal (OO500). Glycemic indicators and the lipid profile were measured in serum before and after the meal, while ex vivo ADP- and TRAP-induced platelet aggregation was also calculated. Indicators of the redox state (TBARS, protein carbonyls, glutathione peroxidase activity in serum and erythrocytes) were also measured. Results: The in vitro study showed that: a) Oleocanthal and oleacein are the only phenolic compounds that exhibited significant antiplatelet activity against both ADP (IC50: 0.32 mM-0.62 mM) and TRAP (IC50: 0.66 mM-0.69 mM), b) Tyrosol and hydroxytyrosol demonstrated the lowest antiplatelet activity, and c) there are three compounds that show different activity against ADP and TRAP. Specifically, oleocanthalic acid and the cyclic aglycone of oleuropein exhibit significant inhibitory action against ADP (IC50: 0.87 mM-0.48 mM), but not against TRAP, while oleomissional exhibits the opposite profile. The in vitro assessment of the antiplatelet action of phenolic extracts from the fats/oils used in the postprandial study showed that there is a dose-dependent inverse relationship between the initial amount of oleocanthal/phenolic compounds and the IC50 expressed in μg of extract/μL of the cell homogenate. Regarding the postprandial study, the glycemic and lipid responses were similar across the meals. However, a prolonged (90-240 minutes) dose-dependent reduction in platelet sensitivity to both ADP (50-100%) and TRAP (20-50%) was observed after meals with oleocanthal compared to meals with olive oil or butter. The antiplatelet effect of OO500 was comparable to that of the ibuprofen meal. Olive oil meals rich in oleocanthal positively affected the postprandial redox profile of the volunteers. Conclusions: Oleocanthal, along with oleacein, exerts the strongest antiplatelet action among other secoiridoids in olive oil, as expressed by the inhibition of platelet aggregation induced by ADP and TRAP in healthy volunteers' platelets. The antiplatelet and antioxidant action of oleocanthal can also be achieved postprandially when consumed as an ingredient of olive oil inconcentrations of 250-500 mg/Kg by patients with Type 2 Diabetes Mellitus within the context of a carbohydrate-rich meal. Therefore, oleocanthal-rich olive oils could serve as daily natural sources of oleocanthal, exerting mild antiplatelet actions, provided that the results of the postprandial study are confirmed by long-term, randomized clinical trials.
Degree
thesis:*- Grantor dc:publisher
- Harokopio University
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Katsa, Maria Efthymia
- Κατσά, Μαρία-Ευθυμία
Subjects
dc:subject × 24- Εξαιρετικά παρθένο ελαιόλαδο
- Ελαιοκανθάλη
- Σεκοϊριδοειδή
- Φαινολικές ενώσεις
- Σακχαρώδης διαβήτης τύπου 2
- Ενεργοποίηση αιμοπεταλίων
- Οξειδωτικό στρες
- Μεταγευματικός δυσμεταβολισμός
- Extra virgin olive oil
- Oleocanthal
- Secoiridoids
- Phenolic compounds
- Type 2 diabetes mellitus
- Platelet activation
- Oxidative stress
- Postprandial dysmetabolism
- Επιστήμες Υγείας
- Ιατρική και Επιστήμες Υγείας
- Νοσηλευτική
- Διατροφή και Διαιτολογία
- Health Sciences
- Medical and Health Sciences
- Nursing
- Nutrition and Dietetics
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/59123